enhances the growth of a pseudointima, backs the Dacron velour that lines the blood interface!', I n (Fig. 2) . The DAP has an approximate stroke volume of 15 C.C.~ Nineteen experiments were performed in 10 anesthetized dogs ventilated with the chest open. Through an incision in the sixth or seventh left intercostal space, the chest was opened and snares were passed around the proximal and distal descending thoracic aorta. The intercostal vessels were tied off at their origin. By means of a roller pump, left heart bypass from the left atrium to the femoral artery was instituted. A longitudinal incision equal to the length of the DAP was made in the thoracic aorta. The DAP was sewn into the aorta with a double row of continuous everting sutures, and the suture line was reinforced with Dacron felt. Sutures were placed so that the addition of the patch did not appreciably increase the diameter of the aorta (Fig. 3 ) .
Large-bore polyethylene catheters were placed in the central aorta via the carotid artery and in the right atrium and left ventricle by direct puncture. Biotronex flow probes were placed around the aortic root and left circumflex coronary artery. The electrocardiogram was recorded via needle electrodes applied subcutaneously to the limbs. Flow probes were connected to a Biotronex 610 electromagnetic flowmeter system, and pressure catheters were connected to Statham strain gauges. Electrocardiogram, right atrial pressure, left ventricular pressure, central aortic pressure, central aortic flow, and left circumflex coronary artery flow were simultaneously displayed and recorded on a direct-writing Sanborn recorder. Hemodynamic parameters were measured with the patch off (control) and compared with the patch on (pumping).
Cardiac output was determined from the aortic flow curve. Stroke volume was taken as cardiac output divided by heart rate per minute. The tension time index was derived from the integrated area under the left ventricular pressure curve. Left ventricular stroke pressure work (SPWLV) in grammeters per beat was calculated from the formula:
where SV is stroke volume and MAP is mean arterial pressure.
Mean systolic ejection rate (MSER) in milliliters per second was calculated from the formula:
Number 3 March, 1973 Dynamic aortic patch 4 where DS is the duration of systole in All data were subjected to statistical analseconds.
ysis. The significance of the differences beSystemic vascular resistance (SVR), extween the control (static patch) and the pressed in resistance units, was calculated experimental (dynamic patch) was deterfrom the formula: mined by a paired t test.
MAP SVR = -2 co
where CO is cardiac output. Table I . Hemodynamic changes with the dynamic aortic patch active trol) and dynamic (pumping) in a normotensive animal. Table I summarizes the hemodynamic changes that occurred when the DAP group was compared to the control group. The tension time index decreased 23. All data were statistically significant at values of p < 0.01.
Results

Fig
Discussion
A device that works on the principle of diastolic augmentation, in order to be hemodynamically effective, must fulfill the following criteria: It must consistently be accurately timedll and driven so that it will effectively (1) reduce the left ventricular afterload and hence the myocardial oxygen consumption, and (2) increase the total coronary blood flow. In addition to a favorable hemodynamic response, a permanently implanted left ventricular support device should be nonthrombogenic and promote the development of a pseudointima at the blood It should be nontraumatic to the blood elements and be durable.
The DAP, a permanent left ventricular assist device, fulfills the above-mentioned criteria. The driving unit is portable and simple to operate as previously reported. 8, l1 Other studies in this laboratory indicate that the DAP creates negligible blood trauma, has minimal thromboembolic potential, and enhances the growth of a pseudointimal layer at the blood interface.x, This study indicates that the DAP is hemodynamically effective as a permanent left ventricular assist device. The decreases in stroke pressure work of the left ventricle, tension time index, left ventricular peak pressure, and systemic vascular resistance indicate that the DAP can improve myocardial function by reducing myocardial tension and hence oxygen demands. The simultaneous increases in the mean systolic ejection rate, coronary blood flow, mean diastolic pressure, and cardiac output point out a generalized metabolic and hemodynamic improvement.
Summary
The hemodynamic effects of a DAP for permanent ventricular assistance by diastolic augmentation were studied in dogs.
Favorable increases in cardiac output, mean diastolic pressure, coronary blood flow, and the mean systolic ejection rate combined with favorable reductions in the tension time index, stroke pressure work of the left ventricle, systemic vascular resistance, and left ventricular peak pressure indicate that the DAP is hemodynamically effective.
The favorable cardiovascular response combined with the ability of the blood interface of the DAP to form a pseudointima indicate that it might be clinically applicable as a permanent left ventricular support device.
